Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology

As the immuno-oncology landscape evolves, developers are facing new challenges in early-phase design, differentiation, and regulatory alignment — all while advancing increasingly complex modalities.